ESMO 2024: Breastfeeding after breast cancer is safe
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after…
Browsing: ESMO
ESMO 2024: Combination therapy reduced agitated delirium in patients with advanced cancers
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common…
ESMO 2024: Immunotherapy benefits for early stage gynaecological cancer
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and…
ESMO 2024: Coaching programme for increased exercise in breast cancer patients
A study on exercise for cancer patients, presented at ESMO 2024, draws on data from…
ESMO 2024: High dose vitamin D3 does not provide benefit for metastatic colorectal cancer
Data from SOLARIS (Alliance A021703), a multicenter double-blind phase III randomised clinical trial of vitamin…
ESMO 2024: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking…
ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer
Trastuzumab deruxtecan shows substantial anti-cancer activity in brain metastases in patients with HER2-positive breast cancer…
ESMO 2024: Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359),…
ESMO 2024: Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given…
ESMO GI: Prevention and early detection of gastrointestinal cancers take on new importance amidst a younger population
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering…